XML 35 R33.htm IDEA: XBRL DOCUMENT v3.19.3
Collaboration Agreements - Transaction Price Related to Consideration Received and Accounts Receivable Allocated to Performance Obligations along with Associated Deferred Revenue (Parenthetical) (Detail) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Unbilled contract asset $ 180,000 $ 0
Deferred revenue 53,988 0
Net unbilled contract asset 126,012 0
Long-term deferred revenue 98,708 $ 136,109
Europe [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Unbilled contract asset 130,000  
Astellas Agreement [Member] | Europe [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Unbilled contract asset 130,000  
Deferred revenue 3,988  
Astellas Agreement [Member] | Europe [Member] | Prepaid Expenses and Other Current Assets [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Net unbilled contract asset 126,000  
AstraZeneca Agreements [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Unbilled contract asset 50,000  
AstraZeneca Agreements [Member] | U.S./RoW [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Unbilled contract asset 50,000  
Deferred revenue 148,600  
Net unbilled contract asset 50,000  
Long-term deferred revenue $ 98,600